Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Interest & Investment Income: 2021-2024

Historic Interest & Investment Income for Janux Therapeutics (JANX) over the last 4 years, with Dec 2024 value amounting to $29.9 million.

  • Janux Therapeutics' Interest & Investment Income rose 40.54% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year increase of 66.73%. This contributed to the annual value of $29.9 million for FY2024, which is 103.28% up from last year.
  • Per Janux Therapeutics' latest filing, its Interest & Investment Income stood at $29.9 million for FY2024, which was up 103.28% from $14.7 million recorded in FY2023.
  • In the past 5 years, Janux Therapeutics' Interest & Investment Income registered a high of $29.9 million during FY2024, and its lowest value of $257,000 during FY2021.
  • For the 3-year period, Janux Therapeutics' Interest & Investment Income averaged around $16.2 million, with its median value being $14.7 million (2023).
  • Data for Janux Therapeutics' Interest & Investment Income shows a peak YoY spiked of 1,468.87% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Janux Therapeutics' Interest & Investment Income stood at $257,000 in 2021, then surged by 1,468.87% to $4.0 million in 2022, then surged by 264.24% to $14.7 million in 2023, then surged by 103.28% to $29.9 million in 2024.